http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017238-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
filingDate 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105017238-B
titleOfInvention A kind of method that chiral spiro-phosphate catalyzes and synthesizes the ketone derivatives of 1,4 benzoxazines of optical activity 2H 2
abstract Optical activity 2H 1 is catalyzed and synthesized the invention discloses a kind of chiral spiro-phosphate, the method of the ketone derivatives of 4 benzoxazine 2, including using benzoxazinone compound and azole compounds as raw material, using chiral spiro-phosphate catalyst as catalyst, react in organic solvent complete, prepare the ketone derivatives of 2H Isosorbide-5-Nitraes benzoxazine 2.The present invention intends utilizing 2H 1 of the asymmetry catalysis azepine Friedel-Crafts reaction method synthesizing optical activity containing trifluoromethyl season Stereocenter, the ketone derivatives of 4 benzoxazine 2, reaction condition is gentle, technique is simple, simple operation, products therefrom has potential good bioactivity, and this will be significant to new medicament screen, while obtained chipal compounds can be used as the intermediate of pharmaceutical synthesis.
priorityDate 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102690227-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3342903-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466852391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15246252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415750396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419921794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17845026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4048638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093

Total number of triples: 38.